Almarai Baby Food Company participates in the European Society for Clinical Nutrition and Metabolism (ESPEN) 2025 Congress in Prague

The Almarai Baby Food Company, a subsidiary of Almarai, participated in the European Society for Clinical Nutrition and Metabolism (ESPEN) 2025 Congress, held at the Prague Congress Centre from 13 to 16 September 2025. The event was attended by more than 3,000 experts and specialists in clinical nutrition from around the world. This participation reflects the company’s commitment to advancing research and innovation in clinical nutrition, and to strengthening the position of Saudi national industries in international scientific forums, in line with Saudi Vision 2030 objectives for developing healthcare industries and enhancing quality of life.

This marks the company’s second consecutive participation, following its presence at ESPEN 2024 in Milan, affirming its continued role in representing the Kingdom as a leading national player in pediatric clinical nutrition and highlighting its industrial and research capabilities on a global stage.

“The participation of Almarai Baby Food Company in this congress reflects Almarai’s broader role in reinforcing the Kingdom’s leadership on the global stage, not only in food and beverage, but also in health-related industries that enhance quality of life. We believe that investing in research and development, nurturing national talent, and expanding international partnerships are essential pillars that strengthen the Kingdom’s position as a global hub for innovation in food and clinical nutrition, aligned with Saudi Vision 2030,” said Faisal Al Fahadi, Executive Vice President for Communication and Corporate Affairs
at Almarai.

“The ESPEN Congress is a leading global platform for scientific and knowledge exchange, and an opportunity to reaffirm our position as a Saudi company specialized in pediatric nutrition, as well as clinical nutrition solutions for inpatients and home care patients. Through our participation this year, we aim to expand our international partnerships and showcase our innovative Saudi-made solutions that contribute to improving healthcare outcomes and enhancing quality of life,” said Dr. Feras Hammoudeh, Head of the Pediatric Nutrition and Clinical Nutrition Division at Almarai Baby Food Company .

As the only Saudi manufacturer specialized in pediatric nutrition and clinical nutrition solutions, Almarai Baby Food Company took part with its dedicated booth at the exhibition accompanying the congress, showcasing a comprehensive range of Saudi-made therapeutic nutrition products. The portfolio includes more than 30 products for infants and children, in addition to more than 15 products for adults, currently distributed in the Saudi market and soon in the GCC region, with exports to more than 7 countries under various brands and private labels.

This participation highlights the company’s continued investment in research and development and its commitment to adopting advanced scientific solutions in clinical nutrition. It reflects its dedication to positioning the Kingdom as a regional hub for healthcare innovation, while actively contributing to national goals through innovation, talent development, and the expansion of nutrition solutions that address community needs. It also demonstrates Almarai’s role in localizing this industry to strengthen food security in line with Vision 2030.

Almarai, as the parent company, continues to provide full support to Almarai Baby Food Company, empowering its growth across local, regional, and international markets, in line with its strategy to enhance food security, promote community health, and contribute to achieving the objectives of Saudi Vision 2030.